Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
May 17, 2024
May 17, 2024
May 16, 2024
May 16, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 14, 2024
May 14, 2024
May 14, 2024
May 14, 2024
May 10, 2024
May 10, 2024
May 9, 2024
May 9, 2024